Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study

PURPOSE: Tegafur/gimeracil/oteracil (S-1) and capecitabine plus oxaliplatin (CAPOX) are standard adjuvant chemotherapies (ACs) administered after gastrectomy to patients with stage II or III gastric cancer. However, the efficacy of AC in elderly patients remains unclear. The objective of this retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seohee, Min, Jae-Seok, Jeong, Sang-Ho, Yoo, Moon-Won, Son, Young-Gil, Oh, Sung Jin, Kim, Jong-Han, Park, Joong-Min, Hur, Hoon, Jee, Ye Seob, Hwang, Sun-Hwi, Jin, Sung-Ho, Lee, Sang Eok, Lee, Young-Joon, Seo, Kyung Won, Park, Sungsoo, Lee, Chang Min, Kim, Chang Hyun, Jeong, In Ho, Lee, Han Hong, Choi, Sung Il, Lee, Sang-Il, Kim, Chan-Young, Chae, Hyundong, Son, Myoung-Won, Pak, Kyung Ho, Kim, Sungsoo, Lee, Moon-Soo, Kim, Hyoung-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980600/
https://www.ncbi.nlm.nih.gov/pubmed/35425655
http://dx.doi.org/10.5230/jgc.2022.22.e6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980600/
https://www.ncbi.nlm.nih.gov/pubmed/35425655
http://dx.doi.org/10.5230/jgc.2022.22.e6

Ejemplares similares